• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于主观反应和早期临床改善预测抗精神病药物治疗的结果。

Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement.

作者信息

Bartkó G, Herczeg I, Békésy M

出版信息

J Clin Psychiatry. 1987 Sep;48(9):363-5.

PMID:3624207
Abstract

The predictive value of the subjective response after 4 hours to an oral test dose of haloperidol and the predictive value of early clinical improvement during a 28-day, fixed-dose regimen with haloperidol were tested in 33 newly admitted schizophrenic patients. A significant (p less than .01) correlation was found between subjective response and therapeutic outcome on Day 28. Five of the 7 patients with dysphoric responses to the test dose had poor therapeutic outcomes. Powerful relationships were found between therapeutic outcome on Day 28 and clinical improvement observed from Day 2 on and between the outcome at discharge and improvement measured on Days 5 and 6.

摘要

在33名新入院的精神分裂症患者中,测试了口服氟哌啶醇试验剂量4小时后的主观反应预测价值,以及在为期28天的氟哌啶醇固定剂量治疗方案期间早期临床改善的预测价值。发现主观反应与第28天的治疗结果之间存在显著相关性(p小于0.01)。对试验剂量有烦躁反应的7名患者中,有5名治疗效果不佳。发现第28天的治疗结果与第2天开始观察到的临床改善之间,以及出院时的结果与第5天和第6天测量的改善之间存在密切关系。

相似文献

1
Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement.基于主观反应和早期临床改善预测抗精神病药物治疗的结果。
J Clin Psychiatry. 1987 Sep;48(9):363-5.
2
Haloperidol plasma level after a test dose as predictor for the clinical response to treatment in acute schizophrenic patients.
Pharmacopsychiatry. 1988 Sep;21(5):226-31. doi: 10.1055/s-2007-1014680.
3
[Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].[红细胞酮还原酶活性、血浆总氟哌啶醇与急性精神病]
Encephale. 1995 Nov-Dec;21(6):417-24.
4
Serum prolactin as a correlate of clinical response to haloperidol.
J Clin Psychopharmacol. 1991 Dec;11(6):357-61.
5
Predictors of therapeutic response to haloperidol in acute schizophrenia.急性精神分裂症患者对氟哌啶醇治疗反应的预测因素
Psychopharmacol Bull. 1991;27(2):97-101.
6
Haloperidol: therapeutic window in schizophrenia.氟哌啶醇:精神分裂症的治疗窗
J Clin Psychopharmacol. 1994 Oct;14(5):303-10.
7
Plasma catecholamine metabolites and early response to haloperidol.血浆儿茶酚胺代谢产物与氟哌啶醇的早期反应
J Clin Psychiatry. 1984 Jun;45(6):248-51.
8
Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.临床药代动力学对精神分裂症患者抗精神病药物治疗的影响。
J Psychiatry Neurosci. 1994 Jul;19(4):254-64.
9
Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects.
Acta Psychiatr Belg. 1983 Jan-Feb;83(1):57-68.
10
Initial improvement as a criterion for drug choice in acute schizophrenia.急性精神分裂症中以初始改善作为药物选择标准。
Pharmacopsychiatry. 1993 Jan;26(1):25-9. doi: 10.1055/s-2007-1014337.

引用本文的文献

1
Association between depression in chronic phase and future clinical outcome of patients with schizophrenia.慢性期抑郁症与精神分裂症患者未来临床结局的关系。
Psychopharmacology (Berl). 2022 Mar;239(3):965-975. doi: 10.1007/s00213-022-06099-4. Epub 2022 Feb 21.
2
Prediction of outcome in schizophrenia using the subjective response to a test dose of a neuroleptic.使用神经安定剂测试剂量的主观反应预测精神分裂症的结果。
Indian J Psychiatry. 1991 Jan;33(1):27-32.
3
Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives.
精神分裂症的随机对照试验:机遇、局限性及试验设计替代方案
Dialogues Clin Neurosci. 2011;13(2):155-72. doi: 10.31887/DCNS.2011.13.2/ccorrell.
4
Pharmacologic treatment of schizophrenia.精神分裂症的药物治疗。
Dialogues Clin Neurosci. 2010;12(3):345-57. doi: 10.31887/DCNS.2010.12.3/jkane.
5
Past and present progress in the pharmacologic treatment of schizophrenia.精神分裂症的药物治疗:过去与现在的进展。
J Clin Psychiatry. 2010 Sep;71(9):1115-24. doi: 10.4088/JCP.10r06264yel.
6
[The initial dysphoric reaction (IDR) to the first dose of neuroleptics].[对首剂抗精神病药物的初始烦躁反应(IDR)]
Nervenarzt. 2004 Jan;75(1):36-43. doi: 10.1007/s00115-003-1544-z.
7
Neuroleptic dysphoria: towards a new synthesis.抗精神病药烦躁不安:迈向新的综合认识
Psychopharmacology (Berl). 2004 Jan;171(2):121-32. doi: 10.1007/s00213-003-1648-y. Epub 2003 Nov 27.